MA47687A - Vecteur de clade f de virus adéno-associé (aav) et ses utilisations - Google Patents
Vecteur de clade f de virus adéno-associé (aav) et ses utilisationsInfo
- Publication number
- MA47687A MA47687A MA047687A MA47687A MA47687A MA 47687 A MA47687 A MA 47687A MA 047687 A MA047687 A MA 047687A MA 47687 A MA47687 A MA 47687A MA 47687 A MA47687 A MA 47687A
- Authority
- MA
- Morocco
- Prior art keywords
- clade
- aav
- adeno
- vector
- associated virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/761—Adenovirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762464748P | 2017-02-28 | 2017-02-28 | |
| PCT/US2018/019992 WO2018160582A1 (fr) | 2017-02-28 | 2018-02-27 | Vecteur de clade f de virus adéno-associé (aav) et ses utilisations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA47687A true MA47687A (fr) | 2021-03-31 |
| MA47687B1 MA47687B1 (fr) | 2024-03-29 |
Family
ID=91034127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA47687A MA47687B1 (fr) | 2017-02-28 | 2018-02-27 | Vecteurs de virus adéno-associé de clade f, et leurs utilisations |
Country Status (1)
| Country | Link |
|---|---|
| MA (1) | MA47687B1 (fr) |
-
2018
- 2018-02-27 MA MA47687A patent/MA47687B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA47687B1 (fr) | 2024-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201905407B (en) | Adeno-associated virus (aav) clade f vector and uses therefor | |
| MA50502A (fr) | Adénovirus et utilisations associées | |
| DK3684423T5 (da) | Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf | |
| EP3585883A4 (fr) | Protéines des capsides aav modifiées et leurs utilisations | |
| EP3658165A4 (fr) | Vecteurs viraux oncolytiques et leurs utilisations | |
| EP4061427A4 (fr) | Variants de vecteurs viraux adéno-associés | |
| IL263801A (en) | Novel adeno-associated virus capsid proteins | |
| EP3589277A4 (fr) | Capsides d'aav modifiées et utilisation de ces dernières | |
| EP3679655C0 (fr) | Authentification d'équipements utilisateurs par l'intermédiaire d'équipements utilisateurs relais | |
| DK3445773T3 (da) | Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf | |
| FR3021319B1 (fr) | Peptides, compositions les comprenant et utilisations notamment cosmetiques | |
| DK3472183T3 (da) | Variant adeno-associerede virus og fremgangsmåder til anvendelse | |
| EP3317999A4 (fr) | Chargement et virtualisation de clés cryptographiques | |
| DK3565568T3 (da) | Ændret virus | |
| EP3362930A4 (fr) | Systèmes, compositions, et procédés de découverte de msi et de néoépitopes qui prévoient la sensibilité à des points de contrôle immunitaires | |
| HUE052577T2 (hu) | Rekombináns GLUT1 adeno-asszociált vírusvektor-szerkezetek és kapcsolódó eljárások GLUT1 expresszió helyreállítására | |
| IL272972A (en) | ADENO-ASSOCIATED VIRUS (AAV with a modified phospholipase region | |
| EP3489354A4 (fr) | Virus de la vaccine recombiné et son utilisation | |
| EP3605290A4 (fr) | Dispositif d'entrée, procédé de configuration de données d'élément et programme | |
| EP3362929A4 (fr) | Néoépitopes viraux et utilisations de ces derniers | |
| EP4312396C0 (fr) | Indication persistante de ressources d'accusé de réception | |
| EP3751000C0 (fr) | Vecteur viral adéno-associé amélioré | |
| EP3302513A4 (fr) | Composition et ses utilisations | |
| SG11201704919SA (en) | Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav) | |
| EP3774848A4 (fr) | Peptides cycliques et utilisations associées |